Kevin R. Nash

Professor

University of South Florida Morsani College of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. Kevin R. Nash is an Assistant Professor at the Morsani College of Medicine, University of South Florida in Tampa, USA. His research primarily focuses on neurological disorders, gene delivery systems, and synaptic plasticity, as reflected in his recent publications. He has explored topics such as tau pathology, vascular dysfunction in diabetic retinas, and the implications of UBE3A protein in the context of Angelman Syndrome and synaptic function.

Articles (11)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Fractalkine (FKN) is a membrane‐bound chemokine that can be cleaved by proteases such as ADAM 10, ADAM 17, and cathepsin S to generate soluble fragments. Studies using different forms of the soluble FKN yield conflicting results in vivo. These observations prompted us to investigate the function and pharmacology of two commonly used isoforms of FKN, a human full‐length soluble FKN (sFKN), and a human chemokine domain only FKN (cdFKN). Both are prevalent in the literature and are often assumed to be functionally equivalent. We observed that recombinant sFKN and cdFKN exhibit similar potencies in a cell‐based cAMP assay, but binding affinity for CX3CR1 was modestly different. There was a 10‐fold difference in potency between sFKN and cdFKN when assessing their ability to stimulate β‐arrestin recruitment. Interestingly, high concentrations of FKN, regardless of cleavage variant, were ineffective at reducing pro‐inflammatory microglial activation and may induce a pro‐inflammatory response. This effect was observed in mouse and rat primary microglial cells as well as microglial cell lines. The inflammatory response was exacerbated in aged microglia, which is known to exhibit age‐related inflammatory phenotypes. We observed the same effects in Cx3cr1−/− primary microglia and therefore speculate that an alternative FKN receptor may exist. Collectively, these data provide greater insights into the function and pharmacology of these common FKN reagents, which may clarify conflicting reports and urge greater caution in the selection of FKN peptides for use in in vitro and in vivo studies and the interpretation of results obtained using these differing peptides.

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

David Segal

Professor and Chair

University of California, Davis

UNITED STATES
View details

Corinna Burger

Associate Professor

University of Wisconsin-Madison

UNITED STATES
View details

Isabel Muzzio

Professor

The University of Iowa

UNITED STATES
View details

David Morgan

Professor

Michigan State University

UNITED STATES
View details

Derek Rodriguez

Assistant Professor

University of Texas Health Science Center at San Antonio

UNITED STATES
View details

Jorge Piedrahita

Distinguished Professor

North Carolina State University

UNITED STATES
View details

Rama Shankar

Assistant Professor

Loyola University Chicago

UNITED STATES
View details

Jason Snyder

Associate Professor

The University of British Columbia

CANADA
View details